Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol

Autores
Almonte, Maribel; Murillo, Jorge Raúl; Sánchez, Gloria Inés; González, Paula; Ferrera, Annabelle; Picconi, María Alejandra; Wiesner, Carolina; Cruz Valdez, Aurelio; Lazcano Ponce, Eduardo; Jerónimo, Jose; Ferreccio, Catterina; Kasamatsu, Elena; Mendoza, Laura; Rodríguez, Guillermo; Calderón, Alejandro; Venegas, Gino; Villagra, Verónica; Tatti, Silvio Alejandro; Fleider, Laura; Terán, Carolina; Baena, Armando; Hernández, María de la Luz; Rol, Mary Luz; Lucas, Eric; Barbier, Sylvaine; Ramírez, Arianis Tatiana; Arrossi, Silvina; Rodríguez, María Isabel; González, Emmanuel; Celis, Marcela; Martínez, Sandra; Salgado, Yuly; Ortega, Marina; Beracochea, Andrea Verónica; Pérez, Natalia; Rodriguez de la Peña, Margarita Mercedes; Ramón, María; Hernández Nevarez, Pilar; Arboleda Naranjo, Margarita; Cabrera, Yessy; Salgado, Brenda; García, Laura; Retana, Marco Antonio; Colucci, María Celeste; Arias-Stella, Javier; Bellido-Fuentes, Yenny; Bobadilla, María Liz; Olmedo, Gladys; Brito García, Ivone; Méndez Herrera, Armando; Cardinal, Lucía Helena; Flores, Betsy; Peñaranda, Jhacquelin; Martínez Better, Josefina; Soilán, Ana; Figueroa, Jacqueline; Caserta, Benedicta; Sosa, Carlos; Moreno, Adrián; Mural, Juan; Doimi, Franco; Giménez, Diana; Rodríguez, Hernando; Lora, Oscar; Luciani, Silvana; Broutet, Nathalie; Darragh, Teresa; Herrero, Rolando
Año de publicación
2020
Idioma
inglés
Tipo de recurso
artículo
Estado
versión publicada
Descripción
Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testing sensitivity, particularly in low-income and middle-income countries (LMICs), where cytology performance has been suboptimal. The ESTAMPA (EStudio multicéntrico de TAMizaje y triaje de cáncer de cuello uterino con pruebas del virus del PApiloma humano; Spanish acronym) study will: (1) evaluate the performance of different triage techniques to detect cervical precancer and (2) inform on how to implement HPV-based screening programmes in LMIC. Methods and analysis Women aged 30-64 years are screened with HPV testing and Pap across 12 study centres in Latin America. Screened positives have colposcopy with biopsy and treatment of lesions. Women with no evident disease are recalled 18 months later for another HPV test; those HPV-positive undergo colposcopy with biopsy and treatment as needed. Biological specimens are collected in different visits for triage testing, which is not used for clinical management. The study outcome is histological high-grade squamous intraepithelial or worse lesions (HSIL+) under the lower anogenital squamous terminology. About 50 000 women will be screened and 500 HSIL+ cases detected (at initial and 18 months screening). Performance measures (sensitivity, specificity and predictive values) of triage techniques to detect HSIL+ will be estimated and compared with adjustment by age and study centre. Ethics and dissemination The study protocol has been approved by the Ethics Committee of the International Agency for Research on Cancer (IARC), of the Pan American Health Organisation (PAHO) and by those in each participating centre. A Data and Safety Monitoring Board (DSMB) has been established to monitor progress of the study, assure participant safety, advice on scientific conduct and analysis and suggest protocol improvements. Study findings will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT01881659
Fil: Almonte, Maribel. International Agency For Research On Cancer; Francia
Fil: Murillo, Jorge Raúl. Pontificia Universidad Javeriana; Colombia
Fil: Sánchez, Gloria Inés. Universidad de Antioquia; Colombia
Fil: González, Paula. Agencia Costarricense de Investigaciones Biomédicas; Costa Rica
Fil: Ferrera, Annabelle. Universidad Nacional Autónoma de Honduras; Honduras
Fil: Picconi, María Alejandra. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentina
Fil: Wiesner, Carolina. Instituto Nacional de Cancerología; Colombia
Fil: Cruz Valdez, Aurelio. Instituto de Salud Pública de México; México
Fil: Lazcano Ponce, Eduardo. Instituto de Salud Pública de México; México
Fil: Jerónimo, Jose. Liga Peruana de Lucha Contra El Cancer; Perú
Fil: Ferreccio, Catterina. Pontificia Universidad Católica de Chile; Chile
Fil: Kasamatsu, Elena. Universidad Nacional de Asunción; Paraguay
Fil: Mendoza, Laura. Universidad Nacional de Asunción; Paraguay
Fil: Rodríguez, Guillermo. Comisión Honoraria de Lucha Contra El Cáncer; Uruguay
Fil: Calderón, Alejandro. Caja Costarricense de Seguro Social; Costa Rica
Fil: Venegas, Gino. Clínica Anglo Americana; Perú. Universidad de Piura (udep); Perú
Fil: Villagra, Verónica. Laboratorio Central de Salud Pública; Paraguay
Fil: Tatti, Silvio Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Fleider, Laura. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Terán, Carolina. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Baena, Armando. International Agency for Research on Cancer; Francia
Fil: Hernández, María de la Luz. Sms-oncology; Países Bajos. International Agency for Research on Cancer; Francia
Fil: Rol, Mary Luz. International Agency for Research on Cancer; Francia
Fil: Lucas, Eric. International Agency for Research on Cancer; Francia
Fil: Barbier, Sylvaine. International Agency for Research on Cancer; Francia
Fil: Ramírez, Arianis Tatiana. International Agency for Research on Cancer; Francia
Fil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Estudios de Estado y Sociedad; Argentina
Fil: Rodríguez, María Isabel. Universidad Nacional de Asunción; Paraguay
Fil: González, Emmanuel. Hospital Dr Enrique Baltodano Briceño; Costa Rica
Fil: Celis, Marcela. Instituto Nacional de Cancerología; Colombia
Fil: Martínez, Sandra. Instituto Nacional de Cancerología; Colombia
Fil: Salgado, Yuly. Instituto Nacional de Cancerología; Colombia
Fil: Ortega, Marina. Hospital Nacional; Paraguay. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Beracochea, Andrea Verónica. Centro de Salud Ciudad de la Costa; Uruguay. Hospital Policial; Uruguay
Fil: Pérez, Natalia. Hospital de Clinicas Dr. Manuel Quintela; Uruguay
Fil: Rodriguez de la Peña, Margarita Mercedes. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Ramón, María. Patología Oncológica Sac; Perú
Fil: Hernández Nevarez, Pilar. Instituto de Salud Pública de México; México
Fil: Arboleda Naranjo, Margarita. Instituto Colombiano de Medicina Tropical; Colombia
Fil: Cabrera, Yessy. Universidad Nacional Autónoma de Honduras; Honduras
Fil: Salgado, Brenda. Secretaría de Salud; Honduras
Fil: García, Laura. Centro Hospitalario Pereira Rossell; Uruguay
Fil: Retana, Marco Antonio. Caja Costarricense de Seguro Social; Costa Rica
Fil: Colucci, María Celeste. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentina
Fil: Arias-Stella, Javier. Instituto de Patología y Biología Molecular Arias Stella; Perú
Fil: Bellido-Fuentes, Yenny. Liga Peruana de Lucha Contra El Cancer; Perú
Fil: Bobadilla, María Liz. Laboratorio Central de Salud Pública; Paraguay
Fil: Olmedo, Gladys. Laboratorio Central de Salud Pública; Paraguay
Fil: Brito García, Ivone. Instituto de Salud Pública de México; México
Fil: Méndez Herrera, Armando. Instituto de Salud Pública de México; México
Fil: Cardinal, Lucía Helena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Flores, Betsy. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Peñaranda, Jhacquelin. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Martínez Better, Josefina. Ese Hospital Antonio Roldán Betancur; Colombia
Fil: Soilán, Ana. Ministerio de Salud Pública y Bienestar Social; Paraguay. Hospital Nacional; Paraguay
Fil: Figueroa, Jacqueline. Programa Nacional Contra El Cáncer; Honduras
Fil: Caserta, Benedicta. Centro Hospitalario Pereira Rossell; Uruguay
Fil: Sosa, Carlos. Hospital Monseñor Víctor Manuel Sanabria Martínez; Costa Rica
Fil: Moreno, Adrián. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Mural, Juan. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Doimi, Franco. Patología Oncológica Sac; Perú
Fil: Giménez, Diana. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Rodríguez, Hernando. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Lora, Oscar. Hospital Gineco-obstétrico y Neonatal "dr Jaime Sánchez Porcel"; Bolivia. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Luciani, Silvana. Pan American Health Organization; Estados Unidos
Fil: Broutet, Nathalie. Organizacion Mundial de la Salud; Argentina
Fil: Darragh, Teresa. University of California; Estados Unidos
Fil: Herrero, Rolando. Instituto Costarricense de Investigacion y Ensenanza En Nutricion y Salud Costa Rica; Costa Rica. International Agency For Research On Cancer; Francia
Materia
COLPOSCOPY
GYNAECOLOGICAL ONCOLOGY
MOLECULAR DIAGNOSTICS
PREVENTIVE MEDICINE
PUBLIC HEALTH
RISK MANAGEMENT
Nivel de accesibilidad
acceso abierto
Condiciones de uso
https://creativecommons.org/licenses/by/2.5/ar/
Repositorio
CONICET Digital (CONICET)
Institución
Consejo Nacional de Investigaciones Científicas y Técnicas
OAI Identificador
oai:ri.conicet.gov.ar:11336/174712

id CONICETDig_07d84345d05a6215770a501b994ba144
oai_identifier_str oai:ri.conicet.gov.ar:11336/174712
network_acronym_str CONICETDig
repository_id_str 3498
network_name_str CONICET Digital (CONICET)
spelling Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocolAlmonte, MaribelMurillo, Jorge RaúlSánchez, Gloria InésGonzález, PaulaFerrera, AnnabellePicconi, María AlejandraWiesner, CarolinaCruz Valdez, AurelioLazcano Ponce, EduardoJerónimo, JoseFerreccio, CatterinaKasamatsu, ElenaMendoza, LauraRodríguez, GuillermoCalderón, AlejandroVenegas, GinoVillagra, VerónicaTatti, Silvio AlejandroFleider, LauraTerán, CarolinaBaena, ArmandoHernández, María de la LuzRol, Mary LuzLucas, EricBarbier, SylvaineRamírez, Arianis TatianaArrossi, SilvinaRodríguez, María IsabelGonzález, EmmanuelCelis, MarcelaMartínez, SandraSalgado, YulyOrtega, MarinaBeracochea, Andrea VerónicaPérez, NataliaRodriguez de la Peña, Margarita MercedesRamón, MaríaHernández Nevarez, PilarArboleda Naranjo, MargaritaCabrera, YessySalgado, BrendaGarcía, LauraRetana, Marco AntonioColucci, María CelesteArias-Stella, JavierBellido-Fuentes, YennyBobadilla, María LizOlmedo, GladysBrito García, IvoneMéndez Herrera, ArmandoCardinal, Lucía HelenaFlores, BetsyPeñaranda, JhacquelinMartínez Better, JosefinaSoilán, AnaFigueroa, JacquelineCaserta, BenedictaSosa, CarlosMoreno, AdriánMural, JuanDoimi, FrancoGiménez, DianaRodríguez, HernandoLora, OscarLuciani, SilvanaBroutet, NathalieDarragh, TeresaHerrero, RolandoCOLPOSCOPYGYNAECOLOGICAL ONCOLOGYMOLECULAR DIAGNOSTICSPREVENTIVE MEDICINEPUBLIC HEALTHRISK MANAGEMENThttps://purl.org/becyt/ford/3.3https://purl.org/becyt/ford/3Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testing sensitivity, particularly in low-income and middle-income countries (LMICs), where cytology performance has been suboptimal. The ESTAMPA (EStudio multicéntrico de TAMizaje y triaje de cáncer de cuello uterino con pruebas del virus del PApiloma humano; Spanish acronym) study will: (1) evaluate the performance of different triage techniques to detect cervical precancer and (2) inform on how to implement HPV-based screening programmes in LMIC. Methods and analysis Women aged 30-64 years are screened with HPV testing and Pap across 12 study centres in Latin America. Screened positives have colposcopy with biopsy and treatment of lesions. Women with no evident disease are recalled 18 months later for another HPV test; those HPV-positive undergo colposcopy with biopsy and treatment as needed. Biological specimens are collected in different visits for triage testing, which is not used for clinical management. The study outcome is histological high-grade squamous intraepithelial or worse lesions (HSIL+) under the lower anogenital squamous terminology. About 50 000 women will be screened and 500 HSIL+ cases detected (at initial and 18 months screening). Performance measures (sensitivity, specificity and predictive values) of triage techniques to detect HSIL+ will be estimated and compared with adjustment by age and study centre. Ethics and dissemination The study protocol has been approved by the Ethics Committee of the International Agency for Research on Cancer (IARC), of the Pan American Health Organisation (PAHO) and by those in each participating centre. A Data and Safety Monitoring Board (DSMB) has been established to monitor progress of the study, assure participant safety, advice on scientific conduct and analysis and suggest protocol improvements. Study findings will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT01881659Fil: Almonte, Maribel. International Agency For Research On Cancer; FranciaFil: Murillo, Jorge Raúl. Pontificia Universidad Javeriana; ColombiaFil: Sánchez, Gloria Inés. Universidad de Antioquia; ColombiaFil: González, Paula. Agencia Costarricense de Investigaciones Biomédicas; Costa RicaFil: Ferrera, Annabelle. Universidad Nacional Autónoma de Honduras; HondurasFil: Picconi, María Alejandra. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; ArgentinaFil: Wiesner, Carolina. Instituto Nacional de Cancerología; ColombiaFil: Cruz Valdez, Aurelio. Instituto de Salud Pública de México; MéxicoFil: Lazcano Ponce, Eduardo. Instituto de Salud Pública de México; MéxicoFil: Jerónimo, Jose. Liga Peruana de Lucha Contra El Cancer; PerúFil: Ferreccio, Catterina. Pontificia Universidad Católica de Chile; ChileFil: Kasamatsu, Elena. Universidad Nacional de Asunción; ParaguayFil: Mendoza, Laura. Universidad Nacional de Asunción; ParaguayFil: Rodríguez, Guillermo. Comisión Honoraria de Lucha Contra El Cáncer; UruguayFil: Calderón, Alejandro. Caja Costarricense de Seguro Social; Costa RicaFil: Venegas, Gino. Clínica Anglo Americana; Perú. Universidad de Piura (udep); PerúFil: Villagra, Verónica. Laboratorio Central de Salud Pública; ParaguayFil: Tatti, Silvio Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Fleider, Laura. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Terán, Carolina. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; BoliviaFil: Baena, Armando. International Agency for Research on Cancer; FranciaFil: Hernández, María de la Luz. Sms-oncology; Países Bajos. International Agency for Research on Cancer; FranciaFil: Rol, Mary Luz. International Agency for Research on Cancer; FranciaFil: Lucas, Eric. International Agency for Research on Cancer; FranciaFil: Barbier, Sylvaine. International Agency for Research on Cancer; FranciaFil: Ramírez, Arianis Tatiana. International Agency for Research on Cancer; FranciaFil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Estudios de Estado y Sociedad; ArgentinaFil: Rodríguez, María Isabel. Universidad Nacional de Asunción; ParaguayFil: González, Emmanuel. Hospital Dr Enrique Baltodano Briceño; Costa RicaFil: Celis, Marcela. Instituto Nacional de Cancerología; ColombiaFil: Martínez, Sandra. Instituto Nacional de Cancerología; ColombiaFil: Salgado, Yuly. Instituto Nacional de Cancerología; ColombiaFil: Ortega, Marina. Hospital Nacional; Paraguay. Ministerio de Salud Pública y Bienestar Social; ParaguayFil: Beracochea, Andrea Verónica. Centro de Salud Ciudad de la Costa; Uruguay. Hospital Policial; UruguayFil: Pérez, Natalia. Hospital de Clinicas Dr. Manuel Quintela; UruguayFil: Rodriguez de la Peña, Margarita Mercedes. Hospital Nacional Profesor Alejandro Posadas; ArgentinaFil: Ramón, María. Patología Oncológica Sac; PerúFil: Hernández Nevarez, Pilar. Instituto de Salud Pública de México; MéxicoFil: Arboleda Naranjo, Margarita. Instituto Colombiano de Medicina Tropical; ColombiaFil: Cabrera, Yessy. Universidad Nacional Autónoma de Honduras; HondurasFil: Salgado, Brenda. Secretaría de Salud; HondurasFil: García, Laura. Centro Hospitalario Pereira Rossell; UruguayFil: Retana, Marco Antonio. Caja Costarricense de Seguro Social; Costa RicaFil: Colucci, María Celeste. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; ArgentinaFil: Arias-Stella, Javier. Instituto de Patología y Biología Molecular Arias Stella; PerúFil: Bellido-Fuentes, Yenny. Liga Peruana de Lucha Contra El Cancer; PerúFil: Bobadilla, María Liz. Laboratorio Central de Salud Pública; ParaguayFil: Olmedo, Gladys. Laboratorio Central de Salud Pública; ParaguayFil: Brito García, Ivone. Instituto de Salud Pública de México; MéxicoFil: Méndez Herrera, Armando. Instituto de Salud Pública de México; MéxicoFil: Cardinal, Lucía Helena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; ArgentinaFil: Flores, Betsy. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; BoliviaFil: Peñaranda, Jhacquelin. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; BoliviaFil: Martínez Better, Josefina. Ese Hospital Antonio Roldán Betancur; ColombiaFil: Soilán, Ana. Ministerio de Salud Pública y Bienestar Social; Paraguay. Hospital Nacional; ParaguayFil: Figueroa, Jacqueline. Programa Nacional Contra El Cáncer; HondurasFil: Caserta, Benedicta. Centro Hospitalario Pereira Rossell; UruguayFil: Sosa, Carlos. Hospital Monseñor Víctor Manuel Sanabria Martínez; Costa RicaFil: Moreno, Adrián. Hospital Nacional Profesor Alejandro Posadas; ArgentinaFil: Mural, Juan. Hospital Nacional Profesor Alejandro Posadas; ArgentinaFil: Doimi, Franco. Patología Oncológica Sac; PerúFil: Giménez, Diana. Ministerio de Salud Pública y Bienestar Social; ParaguayFil: Rodríguez, Hernando. Ministerio de Salud Pública y Bienestar Social; ParaguayFil: Lora, Oscar. Hospital Gineco-obstétrico y Neonatal "dr Jaime Sánchez Porcel"; Bolivia. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; BoliviaFil: Luciani, Silvana. Pan American Health Organization; Estados UnidosFil: Broutet, Nathalie. Organizacion Mundial de la Salud; ArgentinaFil: Darragh, Teresa. University of California; Estados UnidosFil: Herrero, Rolando. Instituto Costarricense de Investigacion y Ensenanza En Nutricion y Salud Costa Rica; Costa Rica. International Agency For Research On Cancer; FranciaBMJ Publishing Group2020-05info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersionhttp://purl.org/coar/resource_type/c_6501info:ar-repo/semantics/articuloapplication/pdfapplication/pdfhttp://hdl.handle.net/11336/174712Almonte, Maribel; Murillo, Jorge Raúl; Sánchez, Gloria Inés; González, Paula; Ferrera, Annabelle; et al.; Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol; BMJ Publishing Group; BMJ Open; 10; 5; 5-2020; 1-142044-6055CONICET DigitalCONICETenginfo:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2019-035796info:eu-repo/semantics/altIdentifier/url/https://bmjopen.bmj.com/content/10/5/e035796info:eu-repo/semantics/openAccesshttps://creativecommons.org/licenses/by/2.5/ar/reponame:CONICET Digital (CONICET)instname:Consejo Nacional de Investigaciones Científicas y Técnicas2025-09-03T09:45:43Zoai:ri.conicet.gov.ar:11336/174712instacron:CONICETInstitucionalhttp://ri.conicet.gov.ar/Organismo científico-tecnológicoNo correspondehttp://ri.conicet.gov.ar/oai/requestdasensio@conicet.gov.ar; lcarlino@conicet.gov.arArgentinaNo correspondeNo correspondeNo correspondeopendoar:34982025-09-03 09:45:44.133CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicasfalse
dc.title.none.fl_str_mv Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
title Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
spellingShingle Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
Almonte, Maribel
COLPOSCOPY
GYNAECOLOGICAL ONCOLOGY
MOLECULAR DIAGNOSTICS
PREVENTIVE MEDICINE
PUBLIC HEALTH
RISK MANAGEMENT
title_short Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
title_full Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
title_fullStr Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
title_full_unstemmed Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
title_sort Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol
dc.creator.none.fl_str_mv Almonte, Maribel
Murillo, Jorge Raúl
Sánchez, Gloria Inés
González, Paula
Ferrera, Annabelle
Picconi, María Alejandra
Wiesner, Carolina
Cruz Valdez, Aurelio
Lazcano Ponce, Eduardo
Jerónimo, Jose
Ferreccio, Catterina
Kasamatsu, Elena
Mendoza, Laura
Rodríguez, Guillermo
Calderón, Alejandro
Venegas, Gino
Villagra, Verónica
Tatti, Silvio Alejandro
Fleider, Laura
Terán, Carolina
Baena, Armando
Hernández, María de la Luz
Rol, Mary Luz
Lucas, Eric
Barbier, Sylvaine
Ramírez, Arianis Tatiana
Arrossi, Silvina
Rodríguez, María Isabel
González, Emmanuel
Celis, Marcela
Martínez, Sandra
Salgado, Yuly
Ortega, Marina
Beracochea, Andrea Verónica
Pérez, Natalia
Rodriguez de la Peña, Margarita Mercedes
Ramón, María
Hernández Nevarez, Pilar
Arboleda Naranjo, Margarita
Cabrera, Yessy
Salgado, Brenda
García, Laura
Retana, Marco Antonio
Colucci, María Celeste
Arias-Stella, Javier
Bellido-Fuentes, Yenny
Bobadilla, María Liz
Olmedo, Gladys
Brito García, Ivone
Méndez Herrera, Armando
Cardinal, Lucía Helena
Flores, Betsy
Peñaranda, Jhacquelin
Martínez Better, Josefina
Soilán, Ana
Figueroa, Jacqueline
Caserta, Benedicta
Sosa, Carlos
Moreno, Adrián
Mural, Juan
Doimi, Franco
Giménez, Diana
Rodríguez, Hernando
Lora, Oscar
Luciani, Silvana
Broutet, Nathalie
Darragh, Teresa
Herrero, Rolando
author Almonte, Maribel
author_facet Almonte, Maribel
Murillo, Jorge Raúl
Sánchez, Gloria Inés
González, Paula
Ferrera, Annabelle
Picconi, María Alejandra
Wiesner, Carolina
Cruz Valdez, Aurelio
Lazcano Ponce, Eduardo
Jerónimo, Jose
Ferreccio, Catterina
Kasamatsu, Elena
Mendoza, Laura
Rodríguez, Guillermo
Calderón, Alejandro
Venegas, Gino
Villagra, Verónica
Tatti, Silvio Alejandro
Fleider, Laura
Terán, Carolina
Baena, Armando
Hernández, María de la Luz
Rol, Mary Luz
Lucas, Eric
Barbier, Sylvaine
Ramírez, Arianis Tatiana
Arrossi, Silvina
Rodríguez, María Isabel
González, Emmanuel
Celis, Marcela
Martínez, Sandra
Salgado, Yuly
Ortega, Marina
Beracochea, Andrea Verónica
Pérez, Natalia
Rodriguez de la Peña, Margarita Mercedes
Ramón, María
Hernández Nevarez, Pilar
Arboleda Naranjo, Margarita
Cabrera, Yessy
Salgado, Brenda
García, Laura
Retana, Marco Antonio
Colucci, María Celeste
Arias-Stella, Javier
Bellido-Fuentes, Yenny
Bobadilla, María Liz
Olmedo, Gladys
Brito García, Ivone
Méndez Herrera, Armando
Cardinal, Lucía Helena
Flores, Betsy
Peñaranda, Jhacquelin
Martínez Better, Josefina
Soilán, Ana
Figueroa, Jacqueline
Caserta, Benedicta
Sosa, Carlos
Moreno, Adrián
Mural, Juan
Doimi, Franco
Giménez, Diana
Rodríguez, Hernando
Lora, Oscar
Luciani, Silvana
Broutet, Nathalie
Darragh, Teresa
Herrero, Rolando
author_role author
author2 Murillo, Jorge Raúl
Sánchez, Gloria Inés
González, Paula
Ferrera, Annabelle
Picconi, María Alejandra
Wiesner, Carolina
Cruz Valdez, Aurelio
Lazcano Ponce, Eduardo
Jerónimo, Jose
Ferreccio, Catterina
Kasamatsu, Elena
Mendoza, Laura
Rodríguez, Guillermo
Calderón, Alejandro
Venegas, Gino
Villagra, Verónica
Tatti, Silvio Alejandro
Fleider, Laura
Terán, Carolina
Baena, Armando
Hernández, María de la Luz
Rol, Mary Luz
Lucas, Eric
Barbier, Sylvaine
Ramírez, Arianis Tatiana
Arrossi, Silvina
Rodríguez, María Isabel
González, Emmanuel
Celis, Marcela
Martínez, Sandra
Salgado, Yuly
Ortega, Marina
Beracochea, Andrea Verónica
Pérez, Natalia
Rodriguez de la Peña, Margarita Mercedes
Ramón, María
Hernández Nevarez, Pilar
Arboleda Naranjo, Margarita
Cabrera, Yessy
Salgado, Brenda
García, Laura
Retana, Marco Antonio
Colucci, María Celeste
Arias-Stella, Javier
Bellido-Fuentes, Yenny
Bobadilla, María Liz
Olmedo, Gladys
Brito García, Ivone
Méndez Herrera, Armando
Cardinal, Lucía Helena
Flores, Betsy
Peñaranda, Jhacquelin
Martínez Better, Josefina
Soilán, Ana
Figueroa, Jacqueline
Caserta, Benedicta
Sosa, Carlos
Moreno, Adrián
Mural, Juan
Doimi, Franco
Giménez, Diana
Rodríguez, Hernando
Lora, Oscar
Luciani, Silvana
Broutet, Nathalie
Darragh, Teresa
Herrero, Rolando
author2_role author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
author
dc.subject.none.fl_str_mv COLPOSCOPY
GYNAECOLOGICAL ONCOLOGY
MOLECULAR DIAGNOSTICS
PREVENTIVE MEDICINE
PUBLIC HEALTH
RISK MANAGEMENT
topic COLPOSCOPY
GYNAECOLOGICAL ONCOLOGY
MOLECULAR DIAGNOSTICS
PREVENTIVE MEDICINE
PUBLIC HEALTH
RISK MANAGEMENT
purl_subject.fl_str_mv https://purl.org/becyt/ford/3.3
https://purl.org/becyt/ford/3
dc.description.none.fl_txt_mv Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testing sensitivity, particularly in low-income and middle-income countries (LMICs), where cytology performance has been suboptimal. The ESTAMPA (EStudio multicéntrico de TAMizaje y triaje de cáncer de cuello uterino con pruebas del virus del PApiloma humano; Spanish acronym) study will: (1) evaluate the performance of different triage techniques to detect cervical precancer and (2) inform on how to implement HPV-based screening programmes in LMIC. Methods and analysis Women aged 30-64 years are screened with HPV testing and Pap across 12 study centres in Latin America. Screened positives have colposcopy with biopsy and treatment of lesions. Women with no evident disease are recalled 18 months later for another HPV test; those HPV-positive undergo colposcopy with biopsy and treatment as needed. Biological specimens are collected in different visits for triage testing, which is not used for clinical management. The study outcome is histological high-grade squamous intraepithelial or worse lesions (HSIL+) under the lower anogenital squamous terminology. About 50 000 women will be screened and 500 HSIL+ cases detected (at initial and 18 months screening). Performance measures (sensitivity, specificity and predictive values) of triage techniques to detect HSIL+ will be estimated and compared with adjustment by age and study centre. Ethics and dissemination The study protocol has been approved by the Ethics Committee of the International Agency for Research on Cancer (IARC), of the Pan American Health Organisation (PAHO) and by those in each participating centre. A Data and Safety Monitoring Board (DSMB) has been established to monitor progress of the study, assure participant safety, advice on scientific conduct and analysis and suggest protocol improvements. Study findings will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT01881659
Fil: Almonte, Maribel. International Agency For Research On Cancer; Francia
Fil: Murillo, Jorge Raúl. Pontificia Universidad Javeriana; Colombia
Fil: Sánchez, Gloria Inés. Universidad de Antioquia; Colombia
Fil: González, Paula. Agencia Costarricense de Investigaciones Biomédicas; Costa Rica
Fil: Ferrera, Annabelle. Universidad Nacional Autónoma de Honduras; Honduras
Fil: Picconi, María Alejandra. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentina
Fil: Wiesner, Carolina. Instituto Nacional de Cancerología; Colombia
Fil: Cruz Valdez, Aurelio. Instituto de Salud Pública de México; México
Fil: Lazcano Ponce, Eduardo. Instituto de Salud Pública de México; México
Fil: Jerónimo, Jose. Liga Peruana de Lucha Contra El Cancer; Perú
Fil: Ferreccio, Catterina. Pontificia Universidad Católica de Chile; Chile
Fil: Kasamatsu, Elena. Universidad Nacional de Asunción; Paraguay
Fil: Mendoza, Laura. Universidad Nacional de Asunción; Paraguay
Fil: Rodríguez, Guillermo. Comisión Honoraria de Lucha Contra El Cáncer; Uruguay
Fil: Calderón, Alejandro. Caja Costarricense de Seguro Social; Costa Rica
Fil: Venegas, Gino. Clínica Anglo Americana; Perú. Universidad de Piura (udep); Perú
Fil: Villagra, Verónica. Laboratorio Central de Salud Pública; Paraguay
Fil: Tatti, Silvio Alejandro. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Fleider, Laura. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Terán, Carolina. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Baena, Armando. International Agency for Research on Cancer; Francia
Fil: Hernández, María de la Luz. Sms-oncology; Países Bajos. International Agency for Research on Cancer; Francia
Fil: Rol, Mary Luz. International Agency for Research on Cancer; Francia
Fil: Lucas, Eric. International Agency for Research on Cancer; Francia
Fil: Barbier, Sylvaine. International Agency for Research on Cancer; Francia
Fil: Ramírez, Arianis Tatiana. International Agency for Research on Cancer; Francia
Fil: Arrossi, Silvina. Consejo Nacional de Investigaciones Científicas y Técnicas. Centro de Estudios de Estado y Sociedad; Argentina
Fil: Rodríguez, María Isabel. Universidad Nacional de Asunción; Paraguay
Fil: González, Emmanuel. Hospital Dr Enrique Baltodano Briceño; Costa Rica
Fil: Celis, Marcela. Instituto Nacional de Cancerología; Colombia
Fil: Martínez, Sandra. Instituto Nacional de Cancerología; Colombia
Fil: Salgado, Yuly. Instituto Nacional de Cancerología; Colombia
Fil: Ortega, Marina. Hospital Nacional; Paraguay. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Beracochea, Andrea Verónica. Centro de Salud Ciudad de la Costa; Uruguay. Hospital Policial; Uruguay
Fil: Pérez, Natalia. Hospital de Clinicas Dr. Manuel Quintela; Uruguay
Fil: Rodriguez de la Peña, Margarita Mercedes. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Ramón, María. Patología Oncológica Sac; Perú
Fil: Hernández Nevarez, Pilar. Instituto de Salud Pública de México; México
Fil: Arboleda Naranjo, Margarita. Instituto Colombiano de Medicina Tropical; Colombia
Fil: Cabrera, Yessy. Universidad Nacional Autónoma de Honduras; Honduras
Fil: Salgado, Brenda. Secretaría de Salud; Honduras
Fil: García, Laura. Centro Hospitalario Pereira Rossell; Uruguay
Fil: Retana, Marco Antonio. Caja Costarricense de Seguro Social; Costa Rica
Fil: Colucci, María Celeste. Dirección Nacional de Institutos de Investigación. Administración Nacional de Laboratorios e Institutos de Salud. Instituto Nacional de Enfermedades Infecciosas; Argentina
Fil: Arias-Stella, Javier. Instituto de Patología y Biología Molecular Arias Stella; Perú
Fil: Bellido-Fuentes, Yenny. Liga Peruana de Lucha Contra El Cancer; Perú
Fil: Bobadilla, María Liz. Laboratorio Central de Salud Pública; Paraguay
Fil: Olmedo, Gladys. Laboratorio Central de Salud Pública; Paraguay
Fil: Brito García, Ivone. Instituto de Salud Pública de México; México
Fil: Méndez Herrera, Armando. Instituto de Salud Pública de México; México
Fil: Cardinal, Lucía Helena. Universidad de Buenos Aires. Facultad de Medicina. Hospital de Clínicas General San Martín; Argentina
Fil: Flores, Betsy. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Peñaranda, Jhacquelin. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Martínez Better, Josefina. Ese Hospital Antonio Roldán Betancur; Colombia
Fil: Soilán, Ana. Ministerio de Salud Pública y Bienestar Social; Paraguay. Hospital Nacional; Paraguay
Fil: Figueroa, Jacqueline. Programa Nacional Contra El Cáncer; Honduras
Fil: Caserta, Benedicta. Centro Hospitalario Pereira Rossell; Uruguay
Fil: Sosa, Carlos. Hospital Monseñor Víctor Manuel Sanabria Martínez; Costa Rica
Fil: Moreno, Adrián. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Mural, Juan. Hospital Nacional Profesor Alejandro Posadas; Argentina
Fil: Doimi, Franco. Patología Oncológica Sac; Perú
Fil: Giménez, Diana. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Rodríguez, Hernando. Ministerio de Salud Pública y Bienestar Social; Paraguay
Fil: Lora, Oscar. Hospital Gineco-obstétrico y Neonatal "dr Jaime Sánchez Porcel"; Bolivia. Universidad Mayor Real y Pontificia de San Francisco Xavier de Chuquisaca; Bolivia
Fil: Luciani, Silvana. Pan American Health Organization; Estados Unidos
Fil: Broutet, Nathalie. Organizacion Mundial de la Salud; Argentina
Fil: Darragh, Teresa. University of California; Estados Unidos
Fil: Herrero, Rolando. Instituto Costarricense de Investigacion y Ensenanza En Nutricion y Salud Costa Rica; Costa Rica. International Agency For Research On Cancer; Francia
description Introduction Human papillomavirus (HPV) testing is replacing cytology in primary screening. Its limited specificity demands using a second (triage) test to better identify women at high-risk of cervical disease. Cytology represents the immediate triage but its low sensitivity might hamper HPV testing sensitivity, particularly in low-income and middle-income countries (LMICs), where cytology performance has been suboptimal. The ESTAMPA (EStudio multicéntrico de TAMizaje y triaje de cáncer de cuello uterino con pruebas del virus del PApiloma humano; Spanish acronym) study will: (1) evaluate the performance of different triage techniques to detect cervical precancer and (2) inform on how to implement HPV-based screening programmes in LMIC. Methods and analysis Women aged 30-64 years are screened with HPV testing and Pap across 12 study centres in Latin America. Screened positives have colposcopy with biopsy and treatment of lesions. Women with no evident disease are recalled 18 months later for another HPV test; those HPV-positive undergo colposcopy with biopsy and treatment as needed. Biological specimens are collected in different visits for triage testing, which is not used for clinical management. The study outcome is histological high-grade squamous intraepithelial or worse lesions (HSIL+) under the lower anogenital squamous terminology. About 50 000 women will be screened and 500 HSIL+ cases detected (at initial and 18 months screening). Performance measures (sensitivity, specificity and predictive values) of triage techniques to detect HSIL+ will be estimated and compared with adjustment by age and study centre. Ethics and dissemination The study protocol has been approved by the Ethics Committee of the International Agency for Research on Cancer (IARC), of the Pan American Health Organisation (PAHO) and by those in each participating centre. A Data and Safety Monitoring Board (DSMB) has been established to monitor progress of the study, assure participant safety, advice on scientific conduct and analysis and suggest protocol improvements. Study findings will be published in peer-reviewed journals and presented at scientific meetings. Trial registration number NCT01881659
publishDate 2020
dc.date.none.fl_str_mv 2020-05
dc.type.none.fl_str_mv info:eu-repo/semantics/article
info:eu-repo/semantics/publishedVersion
http://purl.org/coar/resource_type/c_6501
info:ar-repo/semantics/articulo
format article
status_str publishedVersion
dc.identifier.none.fl_str_mv http://hdl.handle.net/11336/174712
Almonte, Maribel; Murillo, Jorge Raúl; Sánchez, Gloria Inés; González, Paula; Ferrera, Annabelle; et al.; Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol; BMJ Publishing Group; BMJ Open; 10; 5; 5-2020; 1-14
2044-6055
CONICET Digital
CONICET
url http://hdl.handle.net/11336/174712
identifier_str_mv Almonte, Maribel; Murillo, Jorge Raúl; Sánchez, Gloria Inés; González, Paula; Ferrera, Annabelle; et al.; Multicentric study of cervical cancer screening with human papillomavirus testing and assessment of triage methods in Latin America: The ESTAMPA screening study protocol; BMJ Publishing Group; BMJ Open; 10; 5; 5-2020; 1-14
2044-6055
CONICET Digital
CONICET
dc.language.none.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv info:eu-repo/semantics/altIdentifier/doi/10.1136/bmjopen-2019-035796
info:eu-repo/semantics/altIdentifier/url/https://bmjopen.bmj.com/content/10/5/e035796
dc.rights.none.fl_str_mv info:eu-repo/semantics/openAccess
https://creativecommons.org/licenses/by/2.5/ar/
eu_rights_str_mv openAccess
rights_invalid_str_mv https://creativecommons.org/licenses/by/2.5/ar/
dc.format.none.fl_str_mv application/pdf
application/pdf
dc.publisher.none.fl_str_mv BMJ Publishing Group
publisher.none.fl_str_mv BMJ Publishing Group
dc.source.none.fl_str_mv reponame:CONICET Digital (CONICET)
instname:Consejo Nacional de Investigaciones Científicas y Técnicas
reponame_str CONICET Digital (CONICET)
collection CONICET Digital (CONICET)
instname_str Consejo Nacional de Investigaciones Científicas y Técnicas
repository.name.fl_str_mv CONICET Digital (CONICET) - Consejo Nacional de Investigaciones Científicas y Técnicas
repository.mail.fl_str_mv dasensio@conicet.gov.ar; lcarlino@conicet.gov.ar
_version_ 1842268748537397248
score 13.13397